July 2, 2012 — Researchers have announced the results of a study that shows the utility of a six minute walk stress echocardiogram for the early detection of exercise-induced pulmonary arterial hypertension (EIPAH) in patients with connective tissue disease (CTD).

June 29, 2012 — More than 61 companies will display their latest products and services at the American Society of Echocardiography (ASE) Annual Scientific Sessions, June 30-July 3 in National Harbor, Md. Highlights from the show floor, as reported by the vendors, will include:

More than 61 companies will display their latest products and services at the American Society of Echocardiography (ASE) Annual Scientific Sessions, June 30-July 3 in National Harbor, Md. Highlights from the show floor, as reported by the vendors, will include:


June 28, 2012 — The U.S. Supreme Court ruled today that the provision of the Patient Protection and Affordable Care Act (ACA) requiring minimum coverage is valid and is not a constitutional obstruction. The court also ruled that the expansion of Medicaid is within Congress’ spending power. The court ruled that the law is constitutional by a 5-4 vote.

By upholding the Affordable Care Act (ACA), the U.S. Supreme Court has sent a clear message that patients should be the first priority of the American healthcare system, was the response of both the American College of Cardiology (ACC) and the American Heart Association (AHA) following the ruling today.

 

June 28, 2012 — LifeWatch AG, a wireless cardiac monitoring service and home sleep test provider in the United States, presents LifeWatch V, the world’s first-of-its-kind healthcare smartphone.

June 28, 2012 — Infraredx Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, today announced that the company has signed an exclusive five-year agreement with Nipro Corporation to distribute the TVC Imaging System for true vessel characterization of coronary artery disease in Japan.

June 28, 2012 — BiO2 Medical Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colo., announced today that it has received CE mark approval for the Angel catheter, a nitinol inferior vena cava (IVC) filter, permanently attached to a central venous catheter (CVC) for the use of preventing pulmonary embolism (PE) in critically ill patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now